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Abstract
Myopia is the most common ocular disease worldwide. We investigated the association of high myopia with the common
single nucleotide polymorphisms (SNPs) of five candidate genes – early growth response 1 (EGR1), v-fos FBJ murine
osteosarcoma viral oncogene homolog (FOS), jun oncogene (JUN), vasoactive intestinal peptide (VIP), and vasoactive
intestinal peptide receptor 2 (VIPR2). We recruited 1200 unrelated Chinese subjects with 600 cases (spherical equivalent
#28.00 diopters) and 600 controls (spherical equivalent within 61.00 diopter). A discovery sample set was formed from
300 cases and 300 controls, and a replication sample set from the remaining samples. Tag SNPs were genotyped for the
discovery sample set, and the most significant haplotypes and their constituent SNPs were followed up with the replication
sample set. The allele and haplotype frequencies in cases and controls were compared by logistic regression adjusted for
sex and age to give Pa values, and multiple comparisons were corrected by permutation test to give Paemp values. Odd ratios
(OR) were calculated accordingly. In the discovery phase, EGR1, JUN and VIP did not show any significant association while
FOS and VIPR2 demonstrated significant haplotype association with high myopia. In the replication phase, the haplotype
association for VIPR2 was successfully replicated, but not FOS. In analysis combining both sample sets, the most significant
association signals of VIPR2 were the single marker rs2071625 (Pa = 0.0008, Paemp = 0.0046 and OR= 0.75) and the 4-SNP
haplotype window rs2071623-rs2071625-rs2730220-rs885863 (omnibus test, Pa = 9.10e-10 and Paemp = 0.0001) with one
protective haplotype (GGGG: Paemp = 0.0002 and OR= 0.52) and one high-risk haplotype (GAGA: Paemp = 0.0027 and
OR= 4.68). This 4-SNP haplotype window was the most significant in all sample sets examined. This is the first study to
suggest a role of VIPR2 in the genetic susceptibility to high myopia. EGR1, JUN, FOS and VIP are unlikely to be important in
predisposing humans to high myopia.
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Introduction
Myopia is the most common eye disorder worldwide and has
reached epidemic prevalence in East Asia [1]. Myopia can be
classified into different categories based on the clinical entity [2].
High myopia is defined as a refractive error equal to or worse than
26.00 diopters (D). It is the most concerned type because of its
association with irreversible visual impairment such as retinal
detachment, glaucoma and, in severe cases, blindness [3].
Although both environmental and genetic factors play important
roles in the development of myopia [4,5], the principal factor is
still under debate. Cross-sectional studies have shown that
environmental factors such as educational level and near work
are associated with the development of myopia [1,6]. Evidence
pointing to the role of genetic factors in the etiology of myopia
comes mainly from the identification of myopia loci/genes in
linkage and/or association studies [7–15]. Myopia is a complex
disease, and genetic variations can increase the susceptibility to
environmental factors and cause an early onset and/or aggressive
progression. As the age of myopia onset is decreasing [16,17], the
chance of developing high myopia increases. In order to control
the progression of myopia, the underlying pathways leading to this
condition must be understood.
Animal studies show that the development of myopia involves
extracellular matrix (ECM) remodeling of the sclera [18,19].
Therefore, candidate-gene association studies in myopia genetics
have mainly focused on the genes expressed in the sclera [20–23].
However, it is well established that visual experience alters ocular
growth and the changes are first mediated by local visual
processing and signaling mechanisms [24–26]. We hypothesize
that genes directly responsive to visual signals are the primary
genes involved in the biological pathways. Activation of these
genes may further activate other secondary genes in the pathways,
and this in turn causes ECM remodeling of the sclera and
ultimately leads to altered ocular growth. This study aims to
investigate these primary genes for their potential role in the
susceptibility to high myopia. Five functional candidate genes have
been selected on the basis of this hypothesis: early growth response
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1 (EGR1) located at chromosome 5q31.1, v-fos FBJ murine
osteosarcoma viral oncogene homolog (FOS) at 14q24.3, jun
oncogene (JUN) at 1p32-p31, vasoactive intestinal peptide (VIP) at
6q25, vasoactive intestinal peptide receptor 2 (VIPR2) at 7q36.3
(NCBI, http://www.ncbi.nlm.nih.gov/).
Consistent findings from different animal models demonstrate
the participation of Egr-1 (also known as ZENK) in ocular growth
[27–29]. The study of Egr-1 knockout mice has also provided
convincing evidence for the involvement of Egr-1 in regulating
ocular growth [30]. Egr-1 knockout mice had a myopic shift in
refraction and tended to have eyes with a longer axial length. FOS
encodes a protein that dimerizes with the protein encoded by JUN
to form a transcription factor complex known as activating
protein-1 (AP-1) [31]. Binding of AP-1 causes trans-activation of
its target genes. AP-1 sites were found in the promoters of genes
encoding matrix metalloproteinases (MMPs) and their inhibitors
(tissue inhibitor of metalloproteinases or TIMPs) [32,33]. In other
words, AP-1 can regulate the expression of MMPs and TIMPs.
MMPs are capable of degrading ECM proteins and are believed to
be involved in ECM remodeling of the sclera. AP-1 can also
repress the trans-activation of retinoid receptors [34], which have
been shown to be critical for the regulation of eye growth [35].
The expression of VIP showed a positive correlation with the depth
of the vitreous chamber [36] and this suggests that increased
release of VIP may be responsible for ocular growth. VIPR2 is one
of the VIP receptors and is located on chromosome 7q36, which is
within the interval for a putative locus for autosomal dominant
high-grade myopia (formerly called MYP4) [37,38]. The expres-
sion of VIPR2 in the retina and the choroid was altered in chicks
with form-deprivation myopia [39]. These findings suggest a
potential role of VIPR2 in the development of myopia.
We conducted a case-control genetic association study to
investigate the association between high myopia and the five
selected candidate genes. Samples from a homogeneous popula-
tion (southern Han Chinese) were used to minimize the possibility
of false positive results due to population stratification. We also
validated the initial positive findings with an independent sample
set.
Materials and Methods
Recruitment of Subjects
We recruited unrelated Han Chinese aged between 18 and 45
years via the Optometry Clinic of The Hong Kong Polytechnic
University as described previously [9–11]. Cases were subjects
with refraction (spherical equivalent or SE) of 28.00 D or worse
for both eyes while controls were subjects with SE within 61.00 D
for both eyes. Subjects with ocular disease or genetic disease
associated with myopia were excluded from the study. The study
was approved by the Human Subjects Ethics Sub-committee, The
Hong Kong Polytechnic University, and adhered to the tenets of
the Declaration of Helsinki. All participants gave written informed
consent. Eye examination included retinoscopy, fundus examina-
tion, and measurement of refractive error, corneal power, lens
thickness, anterior chamber depth, posterior chamber depth and
axial length [9–11]. In total, we recruited 600 cases and 600
controls, and sequentially allocated them into two sample sets (the
discovery sample set and the replication sample set). Each sample
set consisted of 300 cases and 300 controls.
Selection and genotyping of single nucleotide
polymorphisms (SNPs)
Genomic DNA was extracted from the subjects’ blood samples
[9]. Tag SNPs of the five candidate genes (Table S1) were
identified from the HapMap database (release 23a/phase II
March 08; http://hapmap.ncbi.nlm.nih.gov/) with the selection
criteria of r2.0.8 and minor allele frequency (MAF).0.10 for
Han Chinese population by the Tagger software. The 3-kb regions
upstream and downstream of the candidate genes were included
for SNP selection [11,23].
We genotyped the SNPs by restriction fragment length
polymorphism, unlabelled probe melting curve analysis or primer
extension reaction coupled with denaturing high-performance
liquid chromatography [9–11,23]. We used direct DNA sequenc-
ing of representative samples to confirm all observed genotypes.
Details of the genotyping methods are described in Appendix S1.
Tag SNPs and their genotyping methods are listed in Table S1
together with the respective restriction enzymes, primers, exten-
sion primer, and probes. Tag SNPs showing significant associa-
tions in single-marker or haplotype analyses using the discovery
sample set were followed up with the replication sample set.
Statistical analysis
We used PLINK (ver. 1.07; http://pngu.mgh.harvard.edu/
,purcell/plink/) as the software tool for association analysis [40].
Genotypes of the controls were tested for Hardy-Weinberg
equilibrium (HWE) by exact test with a significance threshold set
at P=0.001 [41]. Single-marker (allelic test) and haplotype
associations were tested using logistic regression adjusted for sex
and age as covariates, and odds ratios (OR) and their 95%
confidence intervals (CI) were also calculated accordingly. We
performed haplotype analysis using an exhaustive sliding-window
approach by testing all possible haplotypes made up of a variable
number of constitutive SNPs. For each sliding window, we jointly
assessed the significance of the haplotype effects by a single case-
control omnibus test with (H – 1) degrees of freedom, where H is
the number of haplotypes for the window concerned. For a
particular window size with a given gene, we conducted the test for
all possible windows of the same size, and shifted one SNP at a
time to the 39 end of the gene. Multiple testing was corrected by
generating empirical P values based on 10 000 permutations
across all SNPs or haplotype windows for a given sample set as
appropriate. To increase the power of the study, the genotype data
were also analyzed by combining the two sample sets with
adjustment for sample set as another covariate in addition to sex
and age. P values adjusted for the covariates are reported, and
indicated as Pa if not corrected for multiple comparisons or as
Paemp if corrected for multiple comparisons. A Paemp,0.05
indicates significant association. Note that the minimum Paemp
value achievable by 10 000 permutations is 0.0001. Linkage
disequilibrium (LD) maps were constructed by Haploview using
solid spine of LD as the definition of haplotype blocks [42].
Results
Subject demographics
Measurements for all traits were highly correlated between the
right and the left eyes, particularly for SE (r = 0.97) and axial
length (r = 0.96). Hence, only measurements for the right eye were
used for analysis. The characteristics of the subjects in the
discovery and the replication sample sets are presented in Table 1.
The average SE values were 0.03 D for controls and 210.56 D for
cases of the discovery sample set, and 0.10 D for controls and
210.06 D for cases of the replication sample set. Most control
subjects had SE between 20.10 D and 0.10 D with about 2.2% of
controls in the range of 0.12 D and 0.40 D. Most case subjects had
SE between 28.00 D and 215.00 D with 4.8% of cases in the
range of less than 215.00 D and 224.00 D. This skewed
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distribution arose as a result of the criteria used for subject
recruitment.
There were fewer females in the control group than in the case
group for the discovery sample set (55.60% vs 73.33%; chi-
squared test, P=9.14661026) and for the replication sample set
(59.33% vs 69.67%; chi-squared test, P=0.0105). The subjects
were younger in the control group than in the case group (mean
age, 24.90 vs 27.75 years; unpaired t test, P=3.0261027) for the
discovery sample set. Although the mean age was similar in both
the control and the case groups (33.34 vs 33.73 years; unpaired t
test, P=0.6118) of the replication sample set, we adjusted for sex
and age in all subsequent association analyses for all sample sets to
maintain consistency across the board.
Discovery sample set
In total, 26 tag SNPs were selected and genotyped for the
discovery sample set: 1 from ERG1, 5 from FOS, 4 from JUN, 3
from VIP and 13 from VIPR2 (Table S1). Table 2 summarizes the
genotype data. The control group was in HWE (P.0.001) for all
26 tag SNPs examined. Therefore, we included all SNPs for
association analysis. In single-marker analysis, six SNPs showed
significant nominal P values (Pa,0.05): rs4645874 (S04) of FOS,
rs1407267 (S01) of VIP, and rs3828963 (S03), rs6973238 (S06),
rs3793227 (S07) and rs2071623 (S10) of VIPR2. However, none of
them remained significant (Paemp,0.05) after correction for
multiple comparisons across 26 SNPs by permutation test.
For candidate genes with two or more tag SNPs examined, we
constructed LD patterns with Haploview and defined LD blocks
by solid spine of LD. In general, LD between SNPs was very weak
with no LD block identified for any of the four genes (FOS, JUN,
VIP and VIPR2) examined for LD patterns (Figures S1A, S1D and
S1E; and Figure 1A). Therefore, we performed haplotype analysis
using an exhaustive sliding-window approach (Table 3). Of all the
123 possible sliding windows, 2 windows of the FOS gene and 13
windows of the VIPR2 gene displayed significant association
(Paemp,0.05) with high myopia even after correction for multiple
comparisons (n = 123) by permutation test. For the FOS gene, the
most significant haplotype window was the 3-SNP window
S03…S05 consisting of rs4645869, rs4645874 and rs17103109
(Pa = 6.43610
25 and Paemp = 0.0016). For the VIPR2 gene, the
most significant haplotype window was the 4-SNP window
S10…S14 made up of rs2071623, rs2071625, rs2730220 and
rs885863 (Pa = 8.47610
28 and Paemp = 0.0001). We, therefore,
followed up these 7 SNPs by genotyping an independent sample
set – the replication sample set (Table 1).
Replication sample set
We examined seven SNPs with the replication sample set
(Table 1) in light of the significant haplotype association obtained
with the discovery sample set. We summarize the genotype data of
the replication sample set in Table 2. The control group was in
HWE for all seven SNPs.
We did not find any significant association in single-marker
analysis of FOS SNPs, not even when we jointly analyzed both
sample sets (hereafter called the combined sample set) (Table 2).
However, single-marker analysis of the replication sample set
revealed significant association of rs2730220 (S12) of VIPR2 with
high myopia even after correction for multiple testing across seven
SNPs (Pa = 0.0017 and Paemp = 0.0110). The OR of its minor allele
A was 0.51 (95% CI, 0.34–0.78) with reference to its major allele
G. Interestingly, instead of rs2730220 (S12), rs2071625 (S11) of
VIPR2 demonstrated significant association with high myopia for
the combined sample sets (Pa = 0.0008 and Paemp = 0.0046) with
the OR of its minor allele G being 0.75 (95% CI, 0.63–0.89).
LD between SNPs was also very weak for FOS and VIPR2 in
both the replication sample set and the combined sample set
(Figures S1B and S1C; and Figures 1B and 1C). We also did not
identify any LD block for these sample sets. Exhaustive sliding-
window haplotype analysis failed to demonstrate any significant
association for FOS for both sample sets (Table 3). However, we
were able to replicate significant haplotype association
(Paemp,0.05) of VIPR2 with high myopia: five significant
haplotype windows for the replication sample set and six
significant haplotype windows for the combined sample set
(Table 3). Most importantly, the same most significant VIPR2
haplotype window was identified as in the discovery sample set:
S10…S13 consisting of rs2071623, rs2071625, rs2730220 and
rs885863 (Pa = 1.15610
25 and Paemp = 0.0002 for the replication
sample set; and Pa = 9.10610
210 and Paemp = 0.0001 for the
combined sample set).
Table 1. Characteristics of subjects in the discovery and the replication sample sets*.
Discovery sample set Replication sample set
Characteristics Controls Cases Controls Cases
Total number 300 300 300 300
Proportion of females, % 55.60 73.33 59.33 69.67
Age (mean 6 SD), years{ 24.9066.10 27.7566.89 33.3469.52 33.7369.09
SE (mean 6 SD), D 0.0360.46 210.5662.49 0.1060.56 210.1662.31
AL (mean 6 SD), mm 23.8560.82 27.7761.15 23.7260.83 27.5561.15
ACD (mean 6 SD), mm 3.6260.35 3.7260.32 3.1860.41 3.3460.39
PCD (mean 6 SD) , mm 16.3060.95 19.9761.21 16.1960.87 19.8961.19
LT (mean 6 SD), mm 3.9460.55 4.0260.55 4.3460.58 4.2960.51
CP (mean 6 SD), D 43.8661.61 44.9161.42 44.1961.50 44.9361.48
*The ocular measurements are based on the data of the right eyes.
{The data of age are missing in 2 controls and 3 cases of the discovery sample set, and 2 controls and 1 case of the replication sample set.
Abbreviations: SD, standard deviation; SE, spherical equivalent; AL, axial length; ACD, anterior chamber depth; PCD, posterior chamber depth; LT, lens thickness; CP,
corneal power; and D, diopter.
doi:10.1371/journal.pone.0061805.t001
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Table 2. Functional candidate genes: summary of genotype data and single-marker association analysis.
Sequential Alleles{ Genotype counts (11/12/22) Minor allele freq P value Pa
Gene SNP No. * (1/2) Cases Controls Cases Controls
(HWE for
controls)
(allelic
association)
Discovery sample set
EGR1 rs11741807 (S01) G/T 183/107/10 188/100/12 0.2117 0.2067 0.9513 0.8602
FOS rs7101 (S01) C/T 81/132/87 95/138/67 0.5100 0.4533 0.2464 0.0816
rs1063169 (S02) G/T 190/96/14 187/95/18 0.2067 0.2183 0.2667 0.5630
rs4645869 (S03) G/A 221/71/8 207/86/7 0.1450 0.1667 0.7724 0.7302
rs4645874 (S04) C/T 224/71/5 206/90/4 0.1350 0.1633 0.1324 0.0208
rs17103109 (S05) T/G 149/127/24 149/130/21 0.2917 0.2867 0.3896 0.0801
JUN rs2104259 (S01) C/G 119/120/61 116/134/50 0.4033 0.3900 0.3325 0.5208
rs2760501 (S02) T/G 199/86/15 192/91/17 0.1933 0.2083 0.2146 0.5752
rs1323288 (S03) A/C 117/139/44 106/142/52 0.3783 0.4100 0.7751 0.4260
rs997768 (S04) T/C 71/174/55 81/153/66 0.4733 0.4750 0.8056 0.8680
VIP rs1407267 (S01) G/T 189/101/10 216/75/9 0.2017 0.1550 0.5332 0.0237
rs12201030 (S02) A/G 226/72/2 239/59/2 0.1267 0.1050 0.6791 0.4515
rs664355 (S03) C/T 230/63/7 238/54/8 0.1283 0.1167 0.0649 0.3953
VIPR2 rs3812311 (S01) A/G 166/111/23 179/91/30 0.2617 0.2517 0.0015 0.9931
rs464260 (S02) A/G 176/118/6 182/112/6 0.2167 0.2067 0.0210 0.7257
rs3828963 (S03) A/T 244/54/2 230/61/9 0.0967 0.1317 0.1175 0.0264
rs3793238 (S04) G/A 228/65/7 233/60/7 0.1317 0.1233 0.2862 0.7567
rs399867 (S05) C/T 150/117/33 167/101/32 0.3050 0.2750 0.0110 0.4522
rs6973238 (S06) T/C 202/82/16 174/95/31 0.1900 0.2617 0.0032 0.0060
rs3793227 (S07) C/T 240/56/4 220/68/12 0.1067 0.1533 0.0532 0.0152
rs2540352 (S08) G/A 195/85/20 202/83/15 0.2083 0.1883 0.1424 0.1436
rs6950938 (S09) G/A 178/92/30 184/98/18 0.2533 0.2233 0.3792 0.1786
rs2071623 (S10) G/A 148/97/55 126/119/55 0.3450 0.3817 0.0077 0.0402
rs2071625 (S11) A/G 158/117/25 135/120/45 0.2783 0.3500 0.0466 0.1585
rs2730220 (S12) G/A 249/41/10 245/49/6 0.1017 0.1017 0.1357 0.0678
rs885863 (S13) G/A 210/83/7 197/95/8 0.1617 0.1850 0.5261 0.1508
Replication sample set
FOS rs4645869 (S03) G/A 214/77/9 213/75/9 1 0.1583 0.1566 0.5072 0.9114
rs4645874 (S04) C/T 235/57/8 242/55/3 0.1217 0.1017 1.0000 0.2633
rs17103109 (S05) T/G 168/114/18 158/117/25 0.2500 0.2783 0.6660 0.2295
VIPR2 rs2071623 (S10) G/A 132/137/31 125/130/45 0.3317 0.3667 0.2632 0.1506
rs2071625 (S11) A/G 145/131/24 124/134/42 0.2983 0.3633 0.5349 0.0169
rs2730220 (S12) ` G/A 259/41/0 232/65/3 0.0683 0.1183 0.7804 0.0017`
rs885863 (S13) G/A 186/95/19 202/91/7 0.2217 0.1750 0.5470 0.0426
Combined sample set
FOS rs4645869 (S03) G/A 435/148/17 420/161/16 1 0.1517 0.1524 0.8802 0.7063
rs4645874 (S04) C/T 459/128/13 448/145/7 0.1283 0.1325 0.2848 0.9602
rs17103109 (S05) T/G 317/241/42 307/247/46 0.2708 0.2825 0.7629 0.5998
VIPR2 rs2071623 (S10) G/A 280/234/86 251/249/100 0.3383 0.3742 0.0053 0.0799
rs2071625 (S11) ` A/G 303/248/49 259/254/87 0.2883 0.3567 0.0616 0.0008`
rs2730220 (S12) G/A 508/82/10 477/114/9 0.0850 0.1100 0.4095 0.0409
rs885863 (S13) G/A 396/178/26 399/186/15 0.1917 0.1800 0.2683 0.4076
*The tag SNPs are listed sequentially from the 59 end to the 39 end of the sense strand of the respective gene, and are also designated in this order as S01, S02, …., etc
for the sake of easy referencing.
{Allele 1 is the major allele, and allele 2 the minor allele.
`In single-marker analysis, these two SNPs were significant even after correction for multiple comparisons: rs2730220 (S12) (Pa = 0.0017 and Paemp = 0.0110) in the
replication sample set; and rs2071625 (S11) ((Pa = 0.0008 and Paemp = 0.0046) in the combined sample set.
1Three control samples failed to be genotyped for rs4645869 even after repeated trials.
doi:10.1371/journal.pone.0061805.t002
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The most significant VIPR2 haplotype window
The 4-SNP haplotype window S10…S13 (rs2071623-
rs2071625-rs2730220-rs885863) of VIPR2 was the most significant
haplotype sliding window in the discovery sample set, the
replication sample set and the combined sample set (Table 3).
The constituent haplotypes of this sliding window are shown in
Table 4. We did not observe any haplotypes displaying opposite
directions of association in the discovery and the replication
sample sets although the GAGA haplotype was found in the
replication sample set, but not in the discovery sample set.
Therefore, the directions of association of these 4-SNP haplotypes
were compatible between the discovery and the replication sample
sets.
In the combined sample set, GGGG (1211) was a protective
haplotype with an OR of 0.52 (Pa = 3.37610
26 and
Paemp = 0.0002) and GAGA (1112) a high-risk haplotype with an
OR of 4.68 (Pa = 0.0001 and Paemp = 0.0027). Note that the
haplotypes are indicated in both the ACGT and the 1–2 (major-
minor) formats. The GGGG (1211) haplotype had a frequency of
9.82% in cases and 16.08% in controls. The GAGA (1112)
haplotype was much less common with a frequency of 3.68% in
cases and 1.45% in controls.
Discussion
Previous studies indicate that genes responsive to visual signals
are involved in the early part of the biological pathways concerned
with altered ocular growth while genes responsible for ECM
remodeling of the sclera participate in the later part of the
pathways [29–31]. Therefore, we selected EGR1, FOS, JUN, VIP
and VIPR2 as functional candidates and investigated their
potential association with high myopia. We assumed a ‘‘common
disease common variants’’ model [43] in this study and hence
selected SNPs, the most abundant sequence variation in the
human genome, as the genetic markers for the present genetic
association study.
We performed haplotype analysis in addition to single-marker
analysis. In the absence of LD block defined for the genes under
study (Figures S1 and 1), we used the variable-sized sliding-
window strategy to further explore possible association by
comprehensively examining haplotype windows of all possible
sizes. This strategy has been shown to be more powerful in
detecting genetic association than single-marker analysis and LD-
block-based haplotype analysis [44]. This is particularly true for
genomic regions of low LD such as candidate loci evaluated in this
study (Figures S1 and 1).
We did not find any evidence to support the role of ERG1, FOS,
JUN and VIP in the genetic susceptibility to high myopia (Tables 2
and 3). We failed to confirm with the replication sample set the
initial significant association of FOS haploypes with high myopia in
the discovery sample set. Our EGR1 data complement a recent
study that assumed a ‘‘common disease rare variants’’ model and
did not find any pathological mutation in the EGR1 coding regions
by DNA sequencing of 96 Chinese subjects with high myopia [45].
On the contrary, we first found the significant association of
VIPR2 haplotypes with high myopia in the discovery sample set
and then successfully replicated the significant association in the
replication sample set (Tables 2 and 3). We found it reassuring that
the haplotype window S10…S13 (rs2071623-rs2071625-
rs2730220-rs885863) was the most significant sliding window
Figure 1. Linkage disequilibrium (LD) patterns for single nucleotide polymorphisms of the VIPR2 gene. LD measures are indicated as r2
values for cases and controls together for (a) the discovery sample set, (B) the replication sample, and (C) the combined sample set. Note that, as
defined by solid spine of LD, no LD bock is identified in any of the sample sets.
doi:10.1371/journal.pone.0061805.g001
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Table 3. Summary of exhaustive haplotype analyses based on omnibus tests for sliding windows of all possible sizes across
separate sets of tag SNPs of the candidate genes*.
Sliding Window (SW) SW with significant omnibus test Paemp,0.05 The most significant result
Gene SNPs/SW No. of SW No. of SW First SW Last SW SW{ Pa Paemp`
Discovery sample set
EGR1 1 1 0 – – S01…S01 0.0816 0.9477
FOS 1 5 0 – – S03…S03 0.0816 0.9477
2 4 0 – – S03…S04 0.0023 0.0750
3 3 1 S03…S05 S03…S05 S03…S05 6.4361025 0.0016
4 2 1 S02…S05 S02…S05 S02…S05 0.0003 0.0070
5 1 0 – – S01…S05 0.0111 0.3371
JUN 1 4 0 – – S03…S03 0.4260 1.0000
2 3 0 – – S01…S02 0.0022 0.0722
3 2 0 – – S01…S03 0.0026 0.0845
4 1 0 – – S01…S04 0.0065 0.2124
VIP 1 3 0 – – S01…S01 0.0237 0.5833
2 2 0 – – S01…S02 0.1110 0.9820
3 1 0 – – S01…S03 0.1720 0.9981
VIPR2 1 13 0 – – S06…S06 0.0060 0.1950
2 12 1 S10…S11 S10…S11 S10…S11 1.8261025 0.0005
3 11 3 S09…S11 S11…S13 S11…S13 5.9361027 0.0001
4 10 2 S09…S12 S10…S13 S10…S13 8.4761028 0.0001
5 9 1 S09…S13 S09…S13 S09…S13 3.1061026 0.0002
6 8 1 S08…S13 S08…S13 S08…S13 6.8761026 0.0003
7 7 2{ S05…S11 S07…S13 S07…S13 9.4561026 0.0003
8 6 2 S05…S12 S06…S13 S06…S13 1.0561024 0.0030
9 5 1 S05…S13 S05…S13 S05…S13 0.0008 0.0256
10 4 0 – – S03…S12 0.0071 0.2277
11 3 0 – – S03…S13 0.0321 0.6881
12 2 0 – – S02…S13 0.0333 0.7015
13 1 0 – – S01…S13 0.0524 0.8463
Replication sample set
FOS 1 3 0 – – S05…S05 0.2290 0.8805
2 2 0 – – S04…S05 0.0315 0.2334
3 1 0 – – S03…S05 0.3800 0.9781
VIPR2 1 4 1 S12…S12 S12…S12 S12…S12 0.0017 0.0141
2 3 2 S11…S12 S12…S13 S11…S12 0.0010 0.0076
3 2 1 S11…S13 S11…S13 S11…S13 0.0032 0.0246
4 1 1 S10…S13 S10…S13 S10…S13 1.1561025 0.0002
Combined sample set
FOS 1 3 0 – – S05…S05 0.6020 0.9998
2 2 0 – – S03…S04 0.2660 0.9184
3 1 0 – – S03…S05 0.1420 0.7269
VIPR2 1 4 1 S11…S11 S11…S11 S11…S11 0.0009 0.0095
2 3 2 S10…S11 S11…S12 S10…S11 7.5161025 0.0005
3 2 2 S10…S12 S11…S13 S11…S13 6.5161025 0.0004
4 1 1 S10…S13 S10…S13 S10…S13 9.10610210 0.0001
*The SW is indicated as Sxx…Syy, where Sxx is the first SNP and the Syy the last SNP of the SW. For each candidate gene, the identity of the SNPs (rs numbers) can be
found in Table 2. Every SW is assessed by omnibus test adjusted for sex and age to give the Pa value. For each fixed-size SW, the most significant result is detailed in the
last three columns. For the discovery sample set, there are a total of 123 SWs across 26 SNPs of the five genes, and multiple comparisons are corrected by running
10,000 permutations to obtain an empirical P value that is also adjusted form sex and age (Paemp). For the replication sample set and the combined sample set,
there are in each sample set 16 SWs across 7 SNPs of the two genes tested, and multiple comparisons are corrected by running 10,000 permutations to obtain the Paemp
values. Note that the minimum Paemp value achievable with 10,000 permutations is 0.0001.
{The SW S06…S12 is between S05…S11 and S07…S13, and is not significant for the omnibus test (Paemp.0.05). Abbreviations: SW, sliding window; Pa, P value adjusted
for sex and age; and Paemp, empirical P value adjusted for sex and age.
doi:10.1371/journal.pone.0061805.t003
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among all possible haplotype windows examined in the discovery,
the replication and the combined sample sets (Table 3). Although
the haplotype GAGA (1112) of the S10…S13 window was
significant in the replication sample set, it was not found in the
discovery sample set (Table 4). Other than this, the directions of
association were consistent for the haplotypes identified in the
discovery and the replication sample sets. In the combined sample
set, we identified one protective haplotype (GGGG or 1211,
OR=0.52) and one high-risk haplotype (GAGA or 1112,
OR=4.68). The high-risk haplotype GAGA was much less
common particularly in the controls: 1.64% (,20 chromosomes
out of 1200 chromosomes) in the discovery sample set and 1.45%
(,17 chromosomes out of 1200 chromosomes) in the replication
sample set. Note that analysis for this rare haplotype might be
subject to random variation.
In the combined sample set, the four constituent SNPs of the
VIPR2 S10…S13 window each contributed independent effects to
the significant haplotype association as shown by conditional
logistic regression: P=5.3761028 for S10 (rs2071623),
P=4.3161027 for S11 (rs2071625), P=0.0181 for S12
(rs2730220) and P=1.0961028 for S13 (rs885863). We note that
these four SNPs are located at the 39 end of the VIPR2 gene
(Figure S2). This region harbors a few sequence features that may
be important in regulating the expression of VIPR2.
The importance of S11 (rs2071625) was highlighted by its
significant association in single-marker analysis (Table 2) and its
being a constituent SNP in all significant haplotype windows (Table 3)
in the combined sample set. In the discovery sample set, S11
(rs2071625) was the only SNP included in all 13 significant haplotype
windows (Table 3) even though it was not associated with highmyopia
as a single marker (Table 2). On the other hand, S12 (rs2730220)
stood out in the replication sample set because of its significant
association as a single marker. In both scenarios, association was
statistically more significant with haplotype windows than with single
markers. Therefore, we speculate that these SNPs or their haplotypes
are more likely tagging some untyped causal variants that drive the
genuine association with high myopia. Nevertheless, some databases
(e.g., Patrocles, http://www.patrocles.org/Patrocles_targets.htm; and
FuncPred, http://manticore.niehs.nih.gov/snpinfo/snpfunc.htm)
predict that S12 (rs2730220) and S13 (rs885863) may affect the
binding of certain microRNAs and hence influence the expression of
VIPR2 accordingly. Despite these predictions, we doubt the
involvement of these SNPs as causal variants in the genetic
susceptibility to high myopia. Therefore, we recommend that future
studies be aimed at identifying the causal variants. Since this is also the
first study that has identified VIPR2 as a myopia susceptibility gene,
our positive results should be replicated using samples from other
populations, particularly those of different ethnicities.
VIPR2, also known as VPAC2, is located on chromosome 7q36
and lies within a putative locus for autosomal dominant high
myopia (once called MYP4) [37,38]. As a G-protein coupled
receptor, VIPR2 is in fact a receptor for VIP. The expression of
VIPR2 in the retina and the choroid was up-regulated in the
treated eyes with reference to the fellow control eyes, but down-
regulated with increasing axial length in chicks with form-
deprivation myopia [39]. An unselective antagonist of VIP
receptors (including VIPR2) could also suppress the development
of form-deprivation myopia in chicks in a dose-dependent manner
[46]. VIPR2 is also an input gene involved in circadian networks.
Intriguingly, some studies have shown that transgenic mice over-
expressing or lacking VIPR2 show deranged circadian rhythms
[47–49]. Interestingly, growing eyes of chicks and monkeys display
a diurnal rhythm in axial length, which is in anti-phase with the
rhythm in choroidal thickness [50]. These phases are distorted in
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eyes that grow too fast or too slowly. Therefore, we speculate that
VIPR2 may influence genetic susceptibility to myopia through its
involvement in circadian rhythms. In light of the significant
association between VIPR2 gene polymorphisms with high
myopia, this hypothesis is worth exploring in future studies.
In summary, EGR1, JUN, FOS and VIP were not associated with
high myopia. However, we identified VIPR2 as a novel myopia
susceptibility gene. We obtained consistent results with sliding-
window haplotype analysis and the S10…S13 haplotype window
(rs2071623-rs2071625-rs2730220-rs885863) was the most signifi-
cant sliding window in all sample sets. In combined sample set,
S11 (rs2071625) also showed significant association with high
myopia as a single marker.
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